As of 2025-12-18, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 43.38 mil USD. MRNS's TTM EBITDA according to its financial statements is -121.83 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 13.8x | 11.8x |
| Forward P/E multiples | 10.8x - 17.2x | 13.6x |
| Fair Price | (23.97) - (30.59) | (28.20) |
| Upside | -4459.0% - -5662.4% | -5227.1% |
| Date | EV/EBITDA |